Patent · US Expired

Benzofurazan compounds which enhance AMPA receptor activity

US6313115A · kind A · utility

0Cited by
5References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 4, 1999
Grant dateNov 6, 2001
Priority date
Expiry dateOct 4, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of general structural formula (I) are shown to have AMPA receptor enhancing properties. The compounds are useful for such therapeutic purposes as facilitating the learning of behaviors dependent upon AMPA receptors, and in treating conditions, such as memory impairment, in which AMPA receptors, or synapses utilizing these receptors, are reduced in numbers or efficiency. They may also be used to enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior. ##STR1##

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.